S'abonner

Nitrous oxide analgesia for rehabilitation after anterior cruciate ligament reconstruction: A randomized controlled trial - 08/10/24

Doi : 10.1016/j.rehab.2024.101897 
Ziyang Wang a, b, 1, Lingjun Zhou c, 1, Fei Wang d, 1, Xiaochen Jiang a, b, Weifeng Wang a, b, Xueling Qiu a, e, Yihui Xing f, Chongjian Fu a, Ping Zhong g, Lu Tang a,
a Department of Stomatology, the 960th Hospital of People's Liberation Army of China (PLA), Jinan,Shandong, 250031, China 
b School of Nursing, Shandong Second Medical University, Weifang, Shandong, 261053, China 
c School of Nursing, Naval Military Medical University, Shanghai, 571623, China 
d Department of Anesthesiology, the 960th Hospital of People's Liberation Army of China (PLA), Jinan, Shandong, 250031, China 
e School of Nursing, Shandong First Medical University, Taian, 271016, China 
f Qingdao Stomatological Hospital, Qingdao, 266001, China 
g Department of rehabilitation medicine, the 960th Hospital of People’ s Liberation Army of China (PLA), Jinan, 250031, China 

Corresponding author: Lu Tang, No. 25 Shifan Road, Tianqiao District, Jinan, Shandong, China. Telephone: +86-0531-51666423.No. 25 Shifan Road, Tianqiao DistrictJinanShandongChina
Sous presse. Manuscrit accepté. Disponible en ligne depuis le Tuesday 08 October 2024
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Highlights

Nitrous oxide reduced rehabilitation pain compared with placebo gas
Nitrous oxide inhalation was associated with few adverse reactions
Physician and participant satisfaction were higher with nitrous oxide than placebo

Le texte complet de cet article est disponible en PDF.

Abstract

Background

: Although there is increasing emphasis on rehabilitation training after ligament reconstruction, little is known about the pain induced by the procedure itself. Procedural success may be limited by pain and anxiety. Nitrous oxide is widely used to alleviate procedural pain. However, few studies have been conducted to show the efficacy and safety of nitrous oxide for rehabilitation training.

Objectives

: To explore the short-term efficacy and safety of nitrous oxide for acute pain elicited by rehabilitation training.

Methods

: A double-blinded randomized placebo-controlled trial was conducted in the department of rehabilitation medicine. People willing to participate in the trial and sign informed consent, ≥18 years old, who had acute pain (self-reported pain score ≥4) caused by rehabilitation training after anterior cruciate ligament reconstruction were recruited. Participants undergoing rehabilitation training were randomized to receive either 65% nitrous oxide or 100% oxygen. The primary outcome was the pain score. Secondary outcomes were sedation score, range of motion, vital signs, physician and participant satisfaction, acceptance, and side effects.

Results

: 120 people were enrolled; 60 received nitrous oxide and 60 received oxygen. The nitrous oxide group had a significantly lower pain score than the placebo group (P < 0.001, median difference -3, 95% CI -4 to -2, effect size η2 = 0.369) and sedation scores (P < 0.001, median difference 1, 95% CI 1 to 1, η2 = 0.263) during the procedure. Both physician (P < 0.001) and participant (P < 0.001) satisfaction were significantly higher in the intervention group than the placebo group. Acceptance (willingness to use the same gas next time) differed between groups (P < 0.001). No serious side effects occurred.

Conclusion

: This study provides evidence supporting the efficacy and safety of self-administered nitrous oxide to reduce procedural pain during rehabilitation training after anterior cruciate ligament reconstruction.

Le texte complet de cet article est disponible en PDF.

Keywords : Anesthesia, Nitrous oxide, Rehabilitation, Anterior cruciate ligament reconstruction

Abbreviations : ACL, ES, MCID, N2O, O2, ROM, RSS, SEM, SRM, VAS


Plan


 Trial registration: Clinical Trial registration number ChiCTR2200061175.


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.